Cancer vaccines are having a renaissance
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreA month ago, Richard Slayman became the first living person to receive a kidney transplant from a gene-edited pig. Now,
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every
Read MoreThis article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every
Read MoreThere is a new most expensive drug ever—a gene therapy that costs as much as a Brooklyn brownstone or a
Read MoreAlex Zhavoronkov has been messing around with artificial intelligence for more than a decade. In 2016, the programmer and physicist
Read MoreOn a bright chilly day last December, a crowd of doctors and scientists gathered at a research institute atop a
Read More